Michael I. Ruxin - Sep 16, 2022 Form 4 Insider Report for THERALINK TECHNOLOGIES, INC. (THER)

Role
Chief Executive Officer, Director
Signature
/s/ Michael I. Ruxin
Stock symbol
THER
Transactions as of
Sep 16, 2022
Transactions value $
$0
Form type
4
Date filed
9/21/2022, 05:44 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THER Stock Option (right to buy) Award $0 +470M $0.00 470M Sep 16, 2022 Common Stock 470M $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 375,790,967 of the stock options will become exercisable upon the filing by the corporation of an S-8 registration statement covering its 2022 Equity Incentive Plan. The remaining 93,947,745 stock options will vest on May 1, 2023.